Page 3 - CIRN Annual Report 2017-18

th
We are delighted to provide our 8 CIRN Annual Report. This year we focused on launching
several new research projects and programs, while also improving the infrastructure, and
operational support that the Network Management Offi ce can provide the networks.

CIRN is working to further strengthen Canada’s chairs of the CIRN Committees, members-at-large,
research capacity, evidence base, and expertise in and one non-voting representative from both PHAC
the fi eld of immunization and vaccines for vaccine- and CIHR.
preventable disease, and plays a pivotal role in
mentoring early-career researchers, recruiting CIRN continues to strengthen and form its fi ve
new investigators, providing opportunities for committees:
trainees, and delivering meaningful engagement of • Indigenous Research Committee (IRC)
stakeholders at all research stages. • Stakeholder Advisory Committee (SAC)

CIRN functions as a network of networks and serves • Scientifi c Advisory Board (SAB)
as a primary source of research capacity to provide • Independent Peer Review Committee (IPRC)
data to inform public health decision-making about • Training and Education Committee (TEC)
immunization programs to improve the health of Over the next year, CIRN aims to work towards
Canadians, and is overseen at the executive level engaging Canada’s provinces on future research
by a Management Committee (MC). The MC is priorities, and looks forward to generating important
comprised of the Nominated Principal Applicant new data to form health policy as we continue to
(NPA) who acts as Chair of the MC, Principal build this important network.
Applicants (PA), who lead the sub-networks, the

CIRN 2018
MANAGEMENT
OUR FOCUS COMMITTEE
• Perform vaccine research to inform health policy
in Canada Dr. Scott Halperin Dr. Philippe De Wals
• Maintain an active research network capable Dr. Julie Bettinger Dr. Shelley Deeks
of immediate response to infectious disease Dr. Joanne Langley Dr. Gaston De Serres
threats in Canada
Dr. Shelly McNeil Ms. Lianne Bellisario,
• Further develop collaborations between representing the
Canadian vaccine experts Dr. Melissa Andrew Public Health Agency
Dr. Karina Top
• Train the next generation of pandemic vaccine of Canada
researchers Dr. Eve Dubé Mr. Steve Mitchell,
• Perform applied public health research and Dr. Natasha Crowcroft representing the
vaccine evaluations of high priority for Canadian Dr. Jeff Kwong Canadian Institutes of
Health Research
health decision-makers Dr. Brian Ward
Dr. Marc Brisson
Dr. David Scheifele
Dr. Mark Loeb

1